{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:26:05Z","timestamp":1772547965481,"version":"3.50.1"},"reference-count":105,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wroclaw Medical University","award":["SUBK.C260.22.043"],"award-info":[{"award-number":["SUBK.C260.22.043"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Non-Hodgkin lymphomas (NHLs) encompass a diverse group of neoplasms arising from the clonal proliferation of B-cell progenitors, T-cell progenitors, mature B-cells, mature T-cells, and natural killer (NK) cells. These malignancies account for over 90% of lymphoid neoplasms. The link between the gut microbiome and neoplasms has been extensively studied in recent years. Growing evidence suggests that the gut microbiome may be involved not only in the development of the disease, but also in modulating the efficacy of implemented therapies. In this review, we summarize the current knowledge on the potential involvement of the gut microbiome in the development of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), mucosa-associated lymphoid tissue (MALT) lymphoma, and NK\/T-cell lymphoma, including cutaneous T-cell lymphoma (CTCL). Moreover, we discuss the relationship between gut microbiome changes before and after treatment and their association with treatment outcomes, focusing on chemotherapy and CAR T-cell therapy.<\/jats:p>","DOI":"10.3390\/cancers17101709","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T06:10:46Z","timestamp":1747721446000},"page":"1709","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of the Gut Microbiome in Non-Hodgkin Lymphoma (NHL): A Focus on Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Cutaneous T-Cell Lymphoma, and NK\/T-Cell Lymphoma"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9622-1593","authenticated-orcid":false,"given":"Magdalena","family":"\u0141yko","sequence":"first","affiliation":[{"name":"Clinical Department of Oncodermatology, University Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Maj","sequence":"additional","affiliation":[{"name":"Clinical Department of General Dermatology, University Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4944-5388","authenticated-orcid":false,"given":"Alina","family":"Jankowska-Konsur","sequence":"additional","affiliation":[{"name":"Clinical Department of Oncodermatology, University Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Berg, G., Rybakova, D., Fischer, D., Cernava, T., Verg\u00e8s, M.C.C., Charles, T., Chen, X., Cocolin, L., Eversole, K., and Corral, G.H. (2020). Microbiome Definition Re-Visited: Old Concepts and New Challenges. Microbiome, 8.","DOI":"10.1186\/s40168-020-00875-0"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1126\/science.1177486","article-title":"Bacterial Community Variation in Human Body Habitats Across Space and Time","volume":"326","author":"Costello","year":"2009","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional Interactions between the Gut Microbiota and Host Metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature18847","article-title":"The Microbiome and Innate Immunity","volume":"535","author":"Thaiss","year":"2016","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The Intestinal Microbiota Fuelling Metabolic Inflammation","volume":"20","author":"Tilg","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The Human Intestinal Microbiome in Health and Disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.clindermatol.2021.08.021","article-title":"The Skin Microbiome and the Gut-Skin Axis","volume":"39","author":"Sinha","year":"2021","journal-title":"Clin. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","article-title":"The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy","volume":"33","author":"Gopalakrishnan","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","article-title":"The Gut Microbiome in Neurological Disorders","volume":"19","author":"Cryan","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Li, C., Liu, H., Lin, Y., Pan, J., and Su, J. (2020). The Gut Microbiota and Respiratory Diseases: New Evidence. J. Immunol. Res.","DOI":"10.1155\/2020\/2340670"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s13238-020-00814-7","article-title":"The Role of the Gut Microbiome and Its Metabolites in Metabolic Diseases","volume":"12","author":"Wu","year":"2021","journal-title":"Protein Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.chom.2018.06.005","article-title":"Mother-to-Infant Microbial Transmission from Different Body Sites Shapes the Developing Infant Gut Microbiome","volume":"24","author":"Ferretti","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11971","DOI":"10.1073\/pnas.1002601107","article-title":"Delivery Mode Shapes the Acquisition and Structure of the Initial Microbiota across Multiple Body Habitats in Newborns","volume":"107","author":"Costello","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.chom.2015.05.012","article-title":"Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life","volume":"17","author":"Roswall","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2014.09.053","article-title":"Human Genetics Shape the Gut Microbiome","volume":"159","author":"Goodrich","year":"2014","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2015.06.014","article-title":"MyD88 Adaptor-Dependent Microbial Sensing by Regulatory T Cells Promotes Mucosal Tolerance and Enforces Commensalism","volume":"43","author":"Wang","year":"2015","journal-title":"Immunity"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet Rapidly and Reproducibly Alters the Human Gut Microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/bs.pmbts.2020.04.006","article-title":"Diet, Nutrients and the Microbiome","volume":"171","author":"Dahl","year":"2020","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2012.10.052","article-title":"Xenobiotics Shape the Physiology and Gene Expression of the Active Human Gut Microbiome","volume":"152","author":"Maurice","year":"2013","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Stewart, C.J., Embleton, N.D., Marrs, E.C.L., Smith, D.P., Fofanova, T., Nelson, A., Skeath, T., Perry, J.D., Petrosino, J.F., and Berrington, J.E. (2017). Longitudinal Development of the Gut Microbiome and Metabolome in Preterm Neonates with Late Onset Sepsis and Healthy Controls. Microbiome, 5.","DOI":"10.1186\/s40168-017-0295-1"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/ismej.2015.177","article-title":"Discordant Temporal Development of Bacterial Phyla and the Emergence of Core in the Fecal Microbiota of Young Children","volume":"10","author":"Cheng","year":"2016","journal-title":"ISME J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the Human Intestinal Microbial Flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nature11319","article-title":"Gut Microbiota Composition Correlates with Diet and Health in the Elderly","volume":"488","author":"Claesson","year":"2012","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ismej.2015.88","article-title":"Composition and Temporal Stability of the Gut Microbiota in Older Persons","volume":"10","author":"Jeffery","year":"2016","journal-title":"ISME J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0022-5193(67)90079-3","article-title":"On the Origin of Mitosing Cells","volume":"14","author":"Sagan","year":"1967","journal-title":"J. Theor. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1073\/pnas.87.12.4576","article-title":"Towards a Natural System of Organisms: Proposal for the Domains Archaea, Bacteria, and Eucarya","volume":"87","author":"Woese","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/2326-6066.CIR-20-0877","article-title":"Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect","volume":"9","author":"Baruch","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.immuni.2014.12.010","article-title":"NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease","volume":"41","author":"Caruso","year":"2014","journal-title":"Immunity"},{"key":"ref_30","first-page":"131","article-title":"Pattern Recognition Receptors in Health and Diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"24192","DOI":"10.1074\/jbc.M109.023044","article-title":"MyD88 Adapter-like (Mal)\/TIRAP Interaction with TRAF6 Is Critical for TLR2- and TLR4-Mediated NF-KappaB Proinflammatory Responses","volume":"284","author":"Verstak","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.abb.2019.02.008","article-title":"NOD-like Receptors and Inflammasomes: A Review of Their Canonical and Non-Canonical Signaling Pathways","volume":"670","author":"Platnich","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Thakur, A., Mikkelsen, H., and Jungersen, G. (2019). Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies. J. Immunol. Res.","DOI":"10.1155\/2019\/1356540"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u039aB, Inflammation, Immunity and Cancer: Coming of Age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Brevi, A., Cogrossi, L.L., Grazia, G., Masciovecchio, D., Impellizzieri, D., Lacanfora, L., Grioni, M., and Bellone, M. (2020). Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.565470"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lawrence, T. (2009). The Nuclear Factor NF-KappaB Pathway in Inflammation. Cold. Spring Harb. Perspect. Biol., 1.","DOI":"10.1101\/cshperspect.a001651"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1182\/blood-2019-121643","article-title":"Alterations of Gut Microbiome in Untreated Chronic Lymphocytic Leukemia (CLL); Future Therapeutic Potentials","volume":"134","author":"Kawari","year":"2019","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2018-99-109761","article-title":"Investigating the Role of the Gut Microbiome in the Inflammatory State of Myeloproliferative Neoplasms","volume":"132","author":"Elalaoui","year":"2018","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1038\/s41467-018-07305-8","article-title":"Microbiota-Driven Interleukin-17-Producing Cells and Eosinophils Synergize to Accelerate Multiple Myeloma Progression","volume":"9","author":"Calcinotto","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Uribe-Herranz, M., Klein-Gonz\u00e1lez, N., Rodr\u00edguez-Lobato, L.G., Juan, M., and de Larrea, C.F. (2021). Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031026"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1158\/0008-5472.CAN-13-0022","article-title":"Intestinal Bacteria Modify Lymphoma Incidence and Latency by Affecting Systemic Inflammatory State, Oxidative Stress, and Leucocyte Genotoxicity","volume":"73","author":"Yamamoto","year":"2013","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/bjc.2011.266","article-title":"Lymphoid Tumours and Breast Cancer in Ataxia Telangiectasia; Substantial Protective Effect of Residual ATM Kinase Activity against Childhood Tumours","volume":"105","author":"Reiman","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-13150-4_1","article-title":"Epidemiology and Etiology of Non-Hodgkin Lymphoma","volume":"165","author":"Chiu","year":"2015","journal-title":"Cancer Treat. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1182\/bloodadvances.2020003129","article-title":"Microbial Dysbiosis Is Associated with Aggressive Histology and Adverse Clinical Outcome in B-Cell Non-Hodgkin Lymphoma","volume":"5","author":"Diefenbach","year":"2021","journal-title":"Blood Adv."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Yuan, L., Wang, W., Zhang, W., Zhang, Y., Wei, C., Li, J., and Zhou, D. (2021). Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.646361"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2081475","DOI":"10.1080\/19490976.2022.2081475","article-title":"Flow Cytometry Can Reliably Capture Gut Microbial Composition in Healthy Adults as Well as Dysbiosis Dynamics in Patients with Aggressive B-Cell Non-Hodgkin Lymphoma","volume":"14","author":"Schmiester","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Lin, Z., Mao, D., Jin, C., Wang, J., Lai, Y., Zhang, Y., Zhou, M., Ge, Q., Zhang, P., and Sun, Y. (2023). The Gut Microbiota Correlate with the Disease Characteristics and Immune Status of Patients with Untreated Diffuse Large B-Cell Lymphoma. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1105293"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/jdv.18125","article-title":"Gut Dysbiosis in Cutaneous T-cell Lymphoma Is Characterized by Shifts in Relative Abundances of Specific Bacterial Taxa and Decreased Diversity in More Advanced Disease","volume":"36","author":"Hooper","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1136\/gutjnl-2022-328256","article-title":"Gut Microbiota as Non-Invasive Diagnostic and Prognostic Biomarkers for Natural Killer\/T-Cell Lymphoma","volume":"72","author":"Shi","year":"2023","journal-title":"Gut"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hon.2717","article-title":"Mucosal Dysbiosis in Patients with Gastrointestinal Follicular Lymphoma","volume":"38","author":"Zeze","year":"2020","journal-title":"Hematol. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e27287","DOI":"10.1097\/MD.0000000000027287","article-title":"Gastric Microbiota in Patients with Helicobacter Pylori-Negative Gastric MALT Lymphoma","volume":"100","author":"Tanaka","year":"2021","journal-title":"Medicine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3892\/ol.2024.14340","article-title":"Characteristics and Prognostic Value of Gut Microbiota in Follicular Lymphoma","volume":"27","author":"Xu","year":"2024","journal-title":"Oncol. Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1182\/bloodadvances.2023012246","article-title":"Dissecting Causal Links between Gut Microbiota, Inflammatory Cytokines, and DLBCL: A Mendelian Randomization Study","volume":"8","author":"Jiang","year":"2024","journal-title":"Blood Adv."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Li, B., Han, Y., Fu, Z., Chai, Y., Guo, X., Du, S., Li, C., and Wang, D. (2024). The Causal Relationship between Gut Microbiota and Lymphoma: A Two-Sample Mendelian Randomization Study. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1397485"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Liang, J., Liu, G., Wang, W., and Xue, H. (2024). Causal Relationships between Gut Microbiota and Lymphoma: A Bidirectional Mendelian Randomization Study. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1374775"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Qian, J., Zheng, W., Fang, J., Cheng, S., Zhang, Y., Zhuang, X., and Song, C. (2024). Causal Relationships of Gut Microbiota, Plasma Metabolites, and Metabolite Ratios with Diffuse Large B-Cell Lymphoma: A Mendelian Randomization Study. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1356437"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.25122\/jml-2018-0035","article-title":"MALT Lymphoma: Epidemiology, Clinical Diagnosis and Treatment","volume":"11","author":"Cuciureanu","year":"2018","journal-title":"J. Med. Life"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.pmbts.2022.07.001","article-title":"Gastrointestinal Microbiome in the Context of Helicobacter Pylori Infection in Stomach and Gastroduodenal Diseases","volume":"192","author":"Retnakumar","year":"2022","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.clindermatol.2013.01.009","article-title":"Role of Infectious Agents in Cutaneous T-Cell Lymphoma: Facts and Controversies","volume":"31","author":"Mirvish","year":"2013","journal-title":"Clin. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaad.2008.08.030","article-title":"Cutaneous T-Cell Lymphoma and Staphylococcus Aureus Colonization","volume":"59","author":"Nguyen","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/1346-8138.16288","article-title":"Pathogenesis of Cutaneous T Cell Lymphoma: Involvement of Staphylococcus Aureus","volume":"49","author":"Fujii","year":"2022","journal-title":"J. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/toxins5081402","article-title":"Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma","volume":"5","author":"Krejsgaard","year":"2013","journal-title":"Toxins"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2133.2006.07312.x","article-title":"Human T-Cell Lymphotropic Virus Type 1 Provirus and Phylogenetic Analysis in Patients with Mycosis Fungoides and Their Family Relatives","volume":"155","author":"Shohat","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/1523-1747.ep12363010","article-title":"Evidence against a Role for Human T-Cell Lymphotrophic Virus Type I (HTLV-I) in the Pathogenesis of American Cutaneous T-Cell Lymphoma","volume":"107","author":"Wood","year":"1996","journal-title":"J. Investig. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/1523-1747.ep12345488","article-title":"Localization of Human T-Cell Lymphotropic Virus-1 Tax Proviral Sequences in Skin Biopsies of Patients with Mycosis Fungoides by in Situ Polymerase Chain Reaction","volume":"106","author":"Khan","year":"1996","journal-title":"J. Investig. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1073\/pnas.88.17.7630","article-title":"Detection of Human T-Lymphotropic Virus-like Particles in Cultures of Peripheral Blood Lymphocytes from Patients with Mycosis Fungoides","volume":"88","author":"Rush","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI117697","article-title":"The Cutaneous T Cell Lymphoma, Mycosis Fungoides, Is a Human T Cell Lymphotropic Virus-Associated Disease: A Study of 50 Patients","volume":"95","author":"Pancake","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"\u0141yko, M., and Jankowska-Konsur, A. (2022). The Skin Microbiome in Cutaneous T-Cell Lymphomas (CTCL)-A Narrative Review. Pathogens, 11.","DOI":"10.3390\/pathogens11080935"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jdv.15951","article-title":"The Gut Microbiome Alterations in Allergic and Inflammatory Skin Diseases\u2014An Update","volume":"34","author":"Gerkowicz","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/all.12549","article-title":"Severity of Atopic Disease Inversely Correlates with Intestinal Microbiota Diversity and Butyrate-Producing Bacteria","volume":"70","author":"Nylund","year":"2015","journal-title":"Allergy"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Oh, B., Boyle, F., Pavlakis, N., Clarke, S., Guminski, A., Eade, T., Lamoury, G., Carroll, S., Morgia, M., and Kneebone, A. (2021). Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.706331"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Aarnoutse, R., Ziemons, J., Penders, J., Rensen, S.S., De Vos-Geelen, J., and Smidt, M.L. (2019). The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174145"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Deng, X., Li, Z., Li, G., Li, B., Jin, X., and Lyu, G. (2018). Comparison of Microbiota in Patients Treated by Surgery or Chemotherapy by 16S RRNA Sequencing Reveals Potential Biomarkers for Colorectal Cancer Therapy. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01607"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13099-019-0299-4","article-title":"Gut Microbiome Associated with Chemotherapy-Induced Diarrhea from the CapeOX Regimen as Adjuvant Chemotherapy in Resected Stage III Colorectal Cancer","volume":"11","author":"Zuo","year":"2019","journal-title":"Gut Pathog."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s11427-018-9456-x","article-title":"Alterations in Intestinal Microbiota of Colorectal Cancer Patients Receiving Radical Surgery Combined with Adjuvant CapeOx Therapy","volume":"62","author":"Kong","year":"2019","journal-title":"Sci. China Life Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"104343","DOI":"10.1016\/j.micpath.2020.104343","article-title":"Effects of Postoperative Adjuvant Chemotherapy and Palliative Chemotherapy on the Gut Microbiome in Colorectal Cancer","volume":"149","author":"Han","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-017-0409-1","article-title":"Characterization of Oral and Gut Microbiome Temporal Variability in Hospitalized Cancer Patients","volume":"9","author":"Smith","year":"2017","journal-title":"Genome Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/cid\/ciz777","article-title":"Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia","volume":"71","author":"Shi","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00248-013-0355-4","article-title":"16S RRNA Gene Pyrosequencing Reveals Shift in Patient Faecal Microbiota during High-Dose Chemotherapy as Conditioning Regimen for Bone Marrow Transplantation","volume":"67","author":"Montassier","year":"2014","journal-title":"Microb. Ecol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13073-016-0301-4","article-title":"Pretreatment Gut Microbiome Predicts Chemotherapy-Related Bloodstream Infection","volume":"8","author":"Montassier","year":"2016","journal-title":"Genome Med."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Uzan-Yulzari, A., Morr, M., Tareef-Nabwani, H., Ziv, O., Magid-Neriya, D., Armoni, R., Muller, E., Leibovici, A., Borenstein, E., and Louzoun, Y. (2020). The Intestinal Microbiome, Weight, and Metabolic Changes in Women Treated by Adjuvant Chemotherapy for Breast and Gynecological Malignancies. BMC Med., 18.","DOI":"10.1186\/s12916-020-01751-2"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/1759-7714.13711","article-title":"Metagenome Association Study of the Gut Microbiome Revealed Biomarkers Linked to Chemotherapy Outcomes in Locally Advanced and Advanced Lung Cancer","volume":"12","author":"Zhao","year":"2021","journal-title":"Thorac. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.2147\/CMAR.S265205","article-title":"Changes of Intestinal Microbiota in Ovarian Cancer Patients Treated with Surgery and Chemotherapy","volume":"12","author":"Tong","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/ijc.32339","article-title":"Overuse of Antianaerobic Drug Is Associated with Poor Postchemotherapy Prognosis of Patients with Hepatocellular Carcinoma","volume":"145","author":"Iida","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/annonc\/mdx108","article-title":"Baseline Gut Microbiota Predicts Clinical Response and Colitis in Metastatic Melanoma Patients Treated with Ipilimumab","volume":"28","author":"Chaput","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.neo.2017.08.004","article-title":"Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients","volume":"19","author":"Frankel","year":"2017","journal-title":"Neoplasia"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The Commensal Microbiome Is Associated with Anti-PD-1 Efficacy in Metastatic Melanoma Patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1158\/1078-0432.CCR-15-0724","article-title":"Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors","volume":"21","author":"Pal","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/hematolrep16010007","article-title":"The Gut Microbiome Correlated to Chemotherapy Efficacy in Diffuse Large B-Cell Lymphoma Patients","volume":"16","author":"Xu","year":"2024","journal-title":"Hematol. Rep."},{"key":"ref_91","first-page":"2224","article-title":"The Influence of Microbial Dysbiosis on Immunochemotherapy-Related Efficacy and Safety in Diffuse Large B-Cell Lymphoma","volume":"141","author":"Yoon","year":"2023","journal-title":"Blood"},{"key":"ref_92","first-page":"93","article-title":"Chimeric Antigen-Receptor T-Cell Therapy for Hematological Malignancies and Solid Tumors: Clinical Data to Date, Current Limitations and Perspectives","volume":"65","author":"Gauthier","year":"2017","journal-title":"Curr. Res. Transl. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/hon.2591","article-title":"CAR T-Cell Therapy: Full Speed Ahead","volume":"37","author":"Sermer","year":"2019","journal-title":"Hematol. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40425-019-0561-9","article-title":"Could the Menagerie of the Gut Microbiome Really Cure Cancer? Hope or Hype","volume":"7","author":"Abid","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40164-019-0155-8","article-title":"Gut Microbiome and CAR-T Therapy","volume":"8","author":"Abid","year":"2019","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Smith, M., Littmann, E., Slingerland, J., Clurman, A., Slingerland, A.E., Taur, Y., Peled, J.U., Park, J., O\u2019Cearbhaill, R., and Mailankody, S. (2019). Intestinal Microbiome Analyses Identify Biomarkers for Patient Response to CAR T Cell Therapy. Biol. Blood Marrow Transplant., 25.","DOI":"10.1016\/j.bbmt.2018.12.319"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41591-022-01702-9","article-title":"Gut Microbiome Correlates of Response and Toxicity Following Anti-CD19 CAR T Cell Therapy","volume":"28","author":"Smith","year":"2022","journal-title":"Nat. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1038\/s41467-022-32960-3","article-title":"CAR-T Cell Therapy-Related Cytokine Release Syndrome and Therapeutic Response Is Modulated by the Gut Microbiome in Hematologic Malignancies","volume":"13","author":"Hu","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41591-023-02234-6","article-title":"A Non-Antibiotic-Disrupted Gut Microbiome Is Associated with Clinical Responses to CD19-CAR-T Cell Cancer Immunotherapy","volume":"29","author":"Saini","year":"2023","journal-title":"Nat. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"100738","DOI":"10.1016\/j.blre.2020.100738","article-title":"Infection Profiles of Different Chemotherapy Regimens and the Clinical Feasibility of Antimicrobial Prophylaxis in Patients with DLBCL","volume":"46","author":"Ohmoto","year":"2021","journal-title":"Blood Rev."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1177\/1078155218795323","article-title":"Is Antimicrobial Prophylaxis Necessary for Lymphoma Patients? A Single Centre, Real-Life Experience","volume":"25","author":"Albayrak","year":"2019","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"617","DOI":"10.6004\/jnccn.2024.0056","article-title":"Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Baden","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"111931","DOI":"10.18632\/oncotarget.22953","article-title":"The Impact of Antibiotic Usage on the Efficacy of Chemoimmunotherapy Is Contingent on the Source of Tumor-Reactive T Cells","volume":"8","author":"Kuczma","year":"2017","journal-title":"Oncotarget"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.2024025366","article-title":"Antibiotic-Induced Loss of Gut Microbiome Metabolic Output Correlates with Clinical Responses to CAR T-Cell Therapy","volume":"145","author":"Prasad","year":"2025","journal-title":"Blood"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/ejh.14207","article-title":"Patients with Aggressive B-Cell Lymphoma Receiving CAR T-Cell Therapy Have a Low Rate of Severe Infections despite Lack of Universal Antibacterial and Antifungal Prophylaxis","volume":"113","author":"Pernas","year":"2024","journal-title":"Eur. J. Haematol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/10\/1709\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:35:34Z","timestamp":1760031334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/10\/1709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":105,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["cancers17101709"],"URL":"https:\/\/doi.org\/10.3390\/cancers17101709","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]}}}